New review out
AHSCT remains the most potent disease-modifying therapy for selected patients with rapidly progressive #dSSc and ILD
🔸RCT evidence, immune reconstitution, long-term outcomes, and future directions
🔗 acrjournals.onlinelibrary.wiley.com/doi/10.1002/ac…
#Rheumatology #SSc #AHSCT #ILD